Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access

Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access

Australian healthtech Everlab has raised AU$65m in Series A funding. The oversubscribed round was led by Airtree Ventures (AU), with participation from global investors including Plural (EU) and existing investors Left Lane Capital (US) and b2venture (EU), alongside angel investors including Australian Test captain Pat Cummins.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616811872/en/

Everlab founding team (L-R): Dr. Steven Lu, Sam Kothari, Anshul Jain, Marc Hermann

The round marks Everlab’s evolution into a complete care platform, transforming the primary care system built to treat illness into one built to prevent it. Today, patients navigate fragmented point solutions that don't connect: legacy providers whose records live in isolation, transactional telehealth appointments with no continuity, and wearables that produce surface-level insights without clinical follow-through.